Boting Zhou

1.1k total citations
35 papers, 848 citations indexed

About

Boting Zhou is a scholar working on Psychiatry and Mental health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Boting Zhou has authored 35 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 12 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Boting Zhou's work include Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Drug Transport and Resistance Mechanisms (9 papers). Boting Zhou is often cited by papers focused on Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Drug Transport and Resistance Mechanisms (9 papers). Boting Zhou collaborates with scholars based in China, United States and South Korea. Boting Zhou's co-authors include Zhaoqian Liu, Xiaojing Xu, Jian Qu, Zhicheng Gong, Qiong Huang, Shuyun Shi, Hong‐Hao Zhou, Yingchun Zhao, Ji‐Ye Yin and Rui Ma and has published in prestigious journals such as Analytical Biochemistry, Scientific Reports and Food Chemistry.

In The Last Decade

Boting Zhou

34 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boting Zhou China 18 285 277 261 223 86 35 848
Yingjie Guo China 20 352 1.2× 230 0.8× 162 0.6× 318 1.4× 24 0.3× 39 957
Noriko Koyabu Japan 21 301 1.1× 379 1.4× 48 0.2× 646 2.9× 45 0.5× 31 1.3k
Brigitte Gerin Belgium 7 226 0.8× 127 0.5× 116 0.4× 132 0.6× 18 0.2× 11 761
Vanessa González-Covarrubias Mexico 15 470 1.6× 130 0.5× 25 0.1× 134 0.6× 43 0.5× 43 1.0k
Hideyuki Motohashi Japan 18 349 1.2× 523 1.9× 48 0.2× 944 4.2× 79 0.9× 43 1.5k
Nobuko Ohmoto Japan 11 188 0.7× 252 0.9× 45 0.2× 470 2.1× 29 0.3× 13 774
Shuzo Moritani Japan 13 274 1.0× 239 0.9× 46 0.2× 389 1.7× 55 0.6× 19 783
Qi Yu China 19 457 1.6× 57 0.2× 19 0.1× 168 0.8× 54 0.6× 50 904
H.J. ten Brink Netherlands 22 732 2.6× 104 0.4× 28 0.1× 57 0.3× 74 0.9× 43 1.3k
Yasuto Kido Japan 13 262 0.9× 252 0.9× 45 0.2× 499 2.2× 34 0.4× 18 881

Countries citing papers authored by Boting Zhou

Since Specialization
Citations

This map shows the geographic impact of Boting Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boting Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boting Zhou more than expected).

Fields of papers citing papers by Boting Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boting Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boting Zhou. The network helps show where Boting Zhou may publish in the future.

Co-authorship network of co-authors of Boting Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Boting Zhou. A scholar is included among the top collaborators of Boting Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boting Zhou. Boting Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cao, Danfeng, Kai Zhang, Xinyu Zhou, et al.. (2024). Inhibition of lysyl oxidase by pharmacological intervention and genetic manipulation alleviates epilepsy-associated cognitive disorder. Brain Research Bulletin. 210. 110928–110928. 1 indexed citations
3.
Yin, Tao, et al.. (2023). A Survey of Therapeutic Drug Monitoring Status in China. Therapeutic Drug Monitoring. 45(2). 151–158. 3 indexed citations
4.
Zhu, Min, et al.. (2021). Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model. European Journal of Clinical Pharmacology. 77(7). 999–1009. 14 indexed citations
5.
6.
7.
Zhou, Boting, et al.. (2019). Determination of unbound valproic acid in plasma using centrifugal ultrafiltration and gas chromatography:Application in TDM. Analytical Biochemistry. 588. 113475–113475. 17 indexed citations
8.
Sun, Shusen, et al.. (2019). Pharmacist impact on adherence of valproic acid therapy in pediatric patients with epilepsy using active education techniques. Epilepsy & Behavior. 98(Pt A). 14–18. 14 indexed citations
9.
Zhang, Mingzhi, Lan-Juan Zhao, Yu Zhou, et al.. (2017). SNP rs11185644 of RXRA gene is identified for dose-response variability to vitamin D3 supplementation: a randomized clinical trial. Scientific Reports. 7(1). 40593–40593. 24 indexed citations
10.
Zhou, Boting, et al.. (2017). High-throughput determination of vancomycin in human plasma by a cost-effective system of two-dimensional liquid chromatography. Journal of Chromatography A. 1499. 48–56. 22 indexed citations
11.
Luo, Jian, et al.. (2016). Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARγ/RXRα Pathway. Frontiers in Pharmacology. 7. 189–189. 15 indexed citations
12.
Qu, Qiang, Jian Qu, Yong Guo, Boting Zhou, & Hong‐Hao Zhou. (2014). Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARγ/OCTN2 pathway. Anti-Cancer Drugs. 25(9). 1016–1027. 24 indexed citations
13.
Li, Xiangping, Ji‐Ye Yin, Ying Wang, et al.. (2014). The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients. Tumor Biology. 35(8). 8259–8265. 17 indexed citations
14.
Qu, Jian, Ying Zhang, Xiao‐Yuan Mao, et al.. (2013). Gene‐Wide Tagging Study of the Association Between KCNT1 Polymorphisms and the Susceptibility and Efficacy of Genetic Generalized Epilepsy in Chinese Population. CNS Neuroscience & Therapeutics. 20(2). 140–146. 17 indexed citations
15.
Zhou, Yu, Lan-Juan Zhao, Xiaojing Xu, et al.. (2013). DNA methylation levels of CYP2R1 and CYP24A1 predict vitamin D response variation. The Journal of Steroid Biochemistry and Molecular Biology. 144. 207–214. 60 indexed citations
16.
17.
Zhou, Boting, Ji‐Ye Yin, Guoliang Li, et al.. (2012). Effects of SCN1A and GABA Receptor Genetic Polymorphisms on Carbamazepine Tolerability and Efficacy in Chinese Patients with Partial Seizures: 2‐Year Longitudinal Clinical Follow‐Up. CNS Neuroscience & Therapeutics. 18(7). 566–572. 41 indexed citations
18.
Huang, Qiong, Guanghua Lei, Ji‐Ye Yin, et al.. (2012). NeuroD1A45T andPAX4R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes. British Journal of Clinical Pharmacology. 74(3). 501–509. 20 indexed citations
19.
Qu, Jian, Boting Zhou, Ji‐Ye Yin, et al.. (2012). ABCC2 Polymorphisms and Haplotype are Associated with Drug Resistance in Chinese Epileptic Patients. CNS Neuroscience & Therapeutics. 18(8). 647–651. 72 indexed citations
20.
Xu, Xiaojing, Huaping Yang, Li Duan, et al.. (2012). The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients. Lung Cancer. 79(1). 65–72. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingjie Guo Breakdown of academic impact, for papers by Noriko Koyabu Breakdown of academic impact, for papers by Brigitte Gerin Breakdown of academic impact, for papers by Vanessa González-Covarrubias Breakdown of academic impact, for papers by Hideyuki Motohashi Breakdown of academic impact, for papers by Nobuko Ohmoto Breakdown of academic impact, for papers by Shuzo Moritani Breakdown of academic impact, for papers by Qi Yu Breakdown of academic impact, for papers by H.J. ten Brink Breakdown of academic impact, for papers by Yasuto Kido
Rankless by CCL
2026